Cargando…

Qualitative hepatitis C virus RNA assay identifies active infection with sufficient viral load for treatment among Phetchabun residents in Thailand

The World Health Organization envisions the elimination of viral hepatitis by 2030 through reducing prevalence and transmission, increasing diagnostic screening, and expanding treatment coverage. Efforts to micro-eliminate hepatitis in Phetchabun province in Thailand, a region where the prevalence o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pratedrat, Pornpitra, Nilyanimit, Pornjarim, Wasitthankasem, Rujipat, Posuwan, Nawarat, Auphimai, Chompoonut, Hansoongnern, Payuda, Pimsing, Napaporn, Ngamnimit, Saranya, Thongmai, Chaiwat, Phaengkha, Wijittra, Wanlapakorn, Nasamon, Vongpunsawad, Sompong, Poovorawan, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9851543/ https://www.ncbi.nlm.nih.gov/pubmed/36656832 http://dx.doi.org/10.1371/journal.pone.0268728

Ejemplares similares

An amino acid substitution in HCV core antigen limits its use as a reliable measure of HCV infection compared with HCV RNA
por: Hansoongnern, Payuda, et al.
Publicado: (2023)

Towards the elimination of viral hepatitis in Thailand by the year 2030
por: Posuwan, Nawarat, et al.
Publicado: (2020)

Antibodies against measles and rubella virus among different age groups in Thailand: A population-based serological survey
por: Wanlapakorn, Nasamon, et al.
Publicado: (2019)

Implementation of hepatitis B vaccine in high-risk young adults with waning immunity
por: Posuwan, Nawarat, et al.
Publicado: (2018)

Serological evidence of hepatitis A, B, and C virus infection in older adults in Khon Kaen, Thailand and the estimated rates of chronic hepatitis B and C virus infection in Thais, 2017
por: Posuwan, Nawarat, et al.
Publicado: (2019)

Assessment of hepatitis C virus infection in two adjacent Thai provinces with drastically different seroprevalence
por: Wasitthankasem, Rujipat, et al.
Publicado: (2017)

HCV core antigen is an alternative marker to HCV RNA for evaluating active HCV infection: implications for improved diagnostic option in an era of affordable DAAs
por: Wasitthankasem, Rujipat, et al.
Publicado: (2017)

Liver disease burden and required treatment expenditures for hepatitis C virus (HCV) infection in Thailand: Implications for HCV elimination in the new therapeutic era, a population-based study
por: Wasitthankasem, Rujipat, et al.
Publicado: (2018)

Birth-cohort HCV screening target in Thailand to expand and optimize the national HCV screening for public health policy
por: Wasitthankasem, Rujipat, et al.
Publicado: (2018)

Dynamics of Cytokine, SARS-CoV-2-Specific IgG, and Neutralizing Antibody Levels in COVID-19 Patients Treated with Convalescent Plasma
por: Pratedrat, Pornpitra, et al.
Publicado: (2023)

Swine Is a Possible Source of Hepatitis E Virus Infection by Comparative Study of Hepatitis A and E Seroprevalence in Thailand
por: Sa-nguanmoo, Pattaratida, et al.
Publicado: (2015)

Molecular epidemiology of the first wave of severe acute respiratory syndrome coronavirus 2 infection in Thailand in 2020
por: Puenpa, Jiratchaya, et al.
Publicado: (2020)

The History of Enterovirus A71 Outbreaks and Molecular Epidemiology in the Asia-Pacific Region
por: Puenpa, Jiratchaya, et al.
Publicado: (2019)

Enterovirus A71 Infection, Thailand, 2017
por: Puenpa, Jiratchaya, et al.
Publicado: (2018)

Seroprevalence of an antibody against diphtheria, tetanus, and pertussis among the elderly in Khon Kaen, Thailand
por: Chinchai, Teeraporn, et al.
Publicado: (2019)

The Success of a Universal Hepatitis B Immunization Program as Part of Thailand’s EPI after 22 Years’ Implementation
por: Posuwan, Nawarat, et al.
Publicado: (2016)

Prevalence of Thymine—Adenine Dinucleotide Repeat, IL28B and IFNL4 in Thai Population and Correlation with Spontaneous Clearance and Treatment Outcome of Hepatitis C Infection
por: Thong, Vo Duy, et al.
Publicado: (2015)

Rotavirus infection in children in Southeast Asia 2008–2018: disease burden, genotype distribution, seasonality, and vaccination
por: Lestari, Fajar Budi, et al.
Publicado: (2020)

Safety and Immunogenicity of the Third Booster Dose with Inactivated, Viral Vector, and mRNA COVID-19 Vaccines in Fully Immunized Healthy Adults with Inactivated Vaccine
por: Kanokudom, Sitthichai, et al.
Publicado: (2022)

Recombinant GII.Pe-GII.4 Norovirus, Thailand, 2017–2018
por: Chuchaona, Watchaporn, et al.
Publicado: (2019)

Immunogenicity Following Two Doses of the BBIBP-CorV Vaccine and a Third Booster Dose with a Viral Vector and mRNA COVID-19 Vaccines against Delta and Omicron Variants in Prime Immunized Adults with Two Doses of the BBIBP-CorV Vaccine
por: Chansaenroj, Jira, et al.
Publicado: (2022)

Respiratory syncytial virus genotypes NA1, ON1, and BA9 are prevalent in Thailand, 2012–2015
por: Thongpan, Ilada, et al.
Publicado: (2017)

Seroprevalence of Antibodies to Pertussis Toxin among Different Age Groups in Thailand after 37 Years of Universal Whole-Cell Pertussis Vaccination
por: Wanlapakorn, Nasamon, et al.
Publicado: (2016)

Antibodies to Bordetella pertussis antigens in maternal and cord blood pairs: a Thai cohort study
por: Wanlapakorn, Nasamon, et al.
Publicado: (2017)

Respiratory syncytial virus, human metapneumovirus, and influenza virus infection in Bangkok, 2016-2017
por: Thongpan, Ilada, et al.
Publicado: (2019)

Strong Correlations between the Binding Antibodies against Wild-Type and Neutralizing Antibodies against Omicron BA.1 and BA.2 Variants of SARS-CoV-2 in Individuals Following Booster (Third-Dose) Vaccination
por: Suntronwong, Nungruthai, et al.
Publicado: (2022)

Chikungunya Outbreak in Bueng Kan Province, Thailand, 2013
por: Wanlapakorn, Nasamon, et al.
Publicado: (2014)

COVID-19 Breakthrough Infection after Inactivated Vaccine Induced Robust Antibody Responses and Cross-Neutralization of SARS-CoV-2 Variants, but Less Immunity against Omicron
por: Suntronwong, Nungruthai, et al.
Publicado: (2022)

Persistence of immunity against Omicron BA.1 and BA.2 variants following homologous and heterologous COVID-19 booster vaccines in healthy adults after a two-dose AZD1222 vaccination
por: Assawakosri, Suvichada, et al.
Publicado: (2022)

SARS-CoV-2 Antibody Dynamics after COVID-19 Vaccination and Infection: A Real-World Cross-Sectional Analysis
por: Yorsaeng, Ritthideach, et al.
Publicado: (2023)

Comparison of the reactogenicity and immunogenicity of a reduced and standard booster dose of the mRNA COVID-19 vaccine in healthy adults after two doses of inactivated vaccine
por: Kanokudom, Sitthichai, et al.
Publicado: (2022)

Decreasing Hepatitis C Virus Infection in Thailand in the Past Decade: Evidence from the 2014 National Survey
por: Wasitthankasem, Rujipat, et al.
Publicado: (2016)

Correction: Decreasing Hepatitis C Virus Infection in Thailand in the Past Decade: Evidence from the 2014 National Survey
por: Wasitthankasem, Rujipat, et al.
Publicado: (2016)

Epidemiology and clinical characteristics of severe acute respiratory infections among hospitalized children under 5 years of age in a tertiary care center in Bangkok, Thailand, 2019–2020
por: Wanlapakorn, Nasamon, et al.
Publicado: (2023)

Evaluation of the effect of maternally derived antibody on response to MMR vaccine in Thai infants
por: Hu, Siyuan, et al.
Publicado: (2022)

Immunogenicity of heterologous inactivated and adenoviral-vectored COVID-19 vaccine: Real-world data
por: Wanlapakorn, Nasamon, et al.
Publicado: (2022)

High prevalence of circulating DS-1-like human rotavirus A and genotype diversity in children with acute gastroenteritis in Thailand from 2016 to 2019
por: Pasittungkul, Siripat, et al.
Publicado: (2021)

High prevalence of DS-1-like rotavirus infection in Thai adults between 2016 and 2019
por: Chansaenroj, Jira, et al.
Publicado: (2020)

Genotypic Distribution of Hepatitis C Virus in Thailand and Southeast Asia
por: Wasitthankasem, Rujipat, et al.
Publicado: (2015)

Safety and Immunogenicity of Standard and Double Doses of Hepatitis B Vaccine in Children after Liver Transplantation: An Open-Label, Randomised Controlled Trial
por: Sintusek, Palittiya, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_81dit95vvirkdjdspckjjqhv92